Literature DB >> 27358403

Complex Formation of Human Proelastases with Procarboxypeptidases A1 and A2.

András Szabó1, Claudia Pilsak2, Melinda Bence1, Heiko Witt3, Miklós Sahin-Tóth4.   

Abstract

The pancreas secretes digestive proenzymes typically in their monomeric form. A notable exception is the ternary complex formed by proproteinase E, chymotrypsinogen C, and procarboxypeptidase A (proCPA) in cattle and other ruminants. In the human and pig pancreas binary complexes of proCPA with proelastases were found. To characterize complex formation among human pancreatic protease zymogens in a systematic manner, we performed binding experiments using recombinant proelastases CELA2A, CELA3A, and CELA3B; chymotrypsinogens CTRB1, CTRB2, CTRC, and CTRL1; and procarboxypeptidases CPA1, CPA2, and CPB1. We found that proCELA3B bound not only to proCPA1 (KD 43 nm) but even more tightly to proCPA2 (KD 18 nm), whereas proCELA2A bound weakly to proCPA1 only (KD 152 nm). Surprisingly, proCELA3A, which shares 92% identity with proCELA3B, did not form stable complexes due to the evolutionary replacement of Ala(241) with Gly. The polymorphic nature of position 241 in both CELA3A (∼4% Ala(241) alleles) and CELA3B (∼2% Gly(241) alleles) points to individual variations in complex formation. The functional effect of complex formation was delayed procarboxypeptidase activation due to increased affinity of the inhibitory activation peptide, whereas proelastase activation was unchanged. We conclude that complex formation among human pancreatic protease zymogens is limited to a subset of proelastases and procarboxypeptidases. Complex formation stabilizes the inhibitory activation peptide of procarboxypeptidases and thereby increases zymogen stability and controls activation.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  complex; elastase; metalloprotease; pancreas; pancreatitis; proteolytic enzyme; serine protease; zymogen activation

Mesh:

Substances:

Year:  2016        PMID: 27358403      PMCID: PMC5016165          DOI: 10.1074/jbc.M116.743237

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

Review 1.  Metallocarboxypeptidases and their protein inhibitors. Structure, function and biomedical properties.

Authors:  J Vendrell; E Querol; F X Avilés
Journal:  Biochim Biophys Acta       Date:  2000-03-07

2.  Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis.

Authors:  H Witt; W Luck; H C Hennies; M Classen; A Kage; U Lass; O Landt; M Becker
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

3.  THE SUBUNIT STRUCTURE OF BOVINE PROCARBOXYPEPTIDASE A-S6. CHEMICAL PROPERTIES AND ENZYMATIC ACTIVITIES OF THE PRODUCTS OF MOLECULAR DISAGGREGATION.

Authors:  J R BROWN; R N GREENSHIELDS; M YAMASAKI; H NEURATH
Journal:  Biochemistry       Date:  1963 Jul-Aug       Impact factor: 3.162

4.  Inactivity of recombinant ELA2B provides a new example of evolutionary elastase silencing in humans.

Authors:  Edit Szepessy; Miklós Sahin-Tóth
Journal:  Pancreatology       Date:  2005-12-01       Impact factor: 3.996

5.  The activation peptide of pancreatic procarboxypeptidase A is the keystone of the bovine procarboxypeptidase A-S6 ternary complex.

Authors:  T Michon; S Granon; P Sauve; C Chapus
Journal:  Biochem Biophys Res Commun       Date:  1991-11-27       Impact factor: 3.575

Review 6.  Pancreatic procarboxypeptidases: oligomeric structures and activation processes revisited.

Authors:  S Ventura; F X Gomis-Rüth; A Puigserver; F X Avilés; J Vendrell
Journal:  Biol Chem       Date:  1997 Mar-Apr       Impact factor: 3.915

7.  Characterization of a silent gene for human pancreatic elastase I: structure of the 5'-flanking region.

Authors:  T Tani; I Kawashima; H Furukawa; T Ohmine; Y Takiguchi
Journal:  J Biochem       Date:  1987-03       Impact factor: 3.387

8.  Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: identity with Rinderknecht's enzyme Y.

Authors:  Richárd Szmola; Miklós Sahin-Tóth
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

9.  Further studies on the human pancreatic binary complexes involving procarboxypeptidase A.

Authors:  M Moulard; T Michon; B Kerfelec; C Chapus
Journal:  FEBS Lett       Date:  1990-02-12       Impact factor: 4.124

10.  Hereditary pancreatitis caused by mutation-induced misfolding of human cationic trypsinogen: a novel disease mechanism.

Authors:  Eva Kereszturi; Richárd Szmola; Zoltán Kukor; Peter Simon; Frank Ulrich Weiss; Markus M Lerch; Miklós Sahin-Tóth
Journal:  Hum Mutat       Date:  2009-04       Impact factor: 4.878

View more
  12 in total

1.  Elastase 3B mutation links to familial pancreatitis with diabetes and pancreatic adenocarcinoma.

Authors:  Paul C Moore; Jessica T Cortez; Chester E Chamberlain; Diana Alba; Amy C Berger; Zoe Quandt; Alice Chan; Mickie H Cheng; Jhoanne L Bautista; Justin Peng; Michael S German; Mark S Anderson; Scott A Oakes
Journal:  J Clin Invest       Date:  2019-08-01       Impact factor: 14.808

2.  Overlapping Specificity of Duplicated Human Pancreatic Elastase 3 Isoforms and Archetypal Porcine Elastase 1 Provides Clues to Evolution of Digestive Enzymes.

Authors:  Eszter Boros; András Szabó; Katalin Zboray; Dávid Héja; Gábor Pál; Miklós Sahin-Tóth
Journal:  J Biol Chem       Date:  2017-01-06       Impact factor: 5.157

3.  Detection of human elastase isoforms by the ScheBo Pancreatic Elastase 1 Test.

Authors:  Anna Zsófia Tóth; András Szabó; Eszter Hegyi; Péter Hegyi; Miklós Sahin-Tóth
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-03-30       Impact factor: 4.052

4.  Loss-of-function variant in chymotrypsin like elastase 3B (CELA3B) is associated with non-alcoholic chronic pancreatitis.

Authors:  Andrea Tóth; Alexandra Demcsák; Florence Zankl; Grzegorz Oracz; Lara Sophie Unger; Peter Bugert; Helmut Laumen; Andrea Párniczky; Péter Hegyi; Jonas Rosendahl; Tomasz Gambin; Rafał Płoski; Dorota Koziel; Stanisław Gluszek; Fredrik Lindgren; J Matthias Löhr; Miklós Sahin-Tóth; Heiko Witt; Agnieszka Magdalena Rygiel; Maren Ewers; Eszter Hegyi
Journal:  Pancreatology       Date:  2022-06-23       Impact factor: 3.977

5.  Diet evolution of carnivorous and herbivorous mammals in Laurasiatheria.

Authors:  Yonghua Wu
Journal:  BMC Ecol Evol       Date:  2022-06-21

6.  Mouse model suggests limited role for human mesotrypsin in pancreatitis.

Authors:  Dóra Mosztbacher; Miklós Sahin-Tóth
Journal:  Pancreatology       Date:  2021-01-22       Impact factor: 3.996

7.  Molecular phyloecology suggests a trophic shift concurrent with the evolution of the first birds.

Authors:  Yonghua Wu
Journal:  Commun Biol       Date:  2021-05-13

8.  Genetic Analysis of Human Chymotrypsin-Like Elastases 3A and 3B (CELA3A and CELA3B) to Assess the Role of Complex Formation between Proelastases and Procarboxypeptidases in Chronic Pancreatitis.

Authors:  Andrea Párniczky; Eszter Hegyi; Anna Zsófia Tóth; Ákos Szücs; Andrea Szentesi; Áron Vincze; Ferenc Izbéki; Balázs Csaba Németh; Péter Hegyi; Miklós Sahin-Tóth
Journal:  Int J Mol Sci       Date:  2016-12-20       Impact factor: 5.923

9.  Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis.

Authors:  Jonas Rosendahl; Holger Kirsten; Eszter Hegyi; Peter Kovacs; Frank Ulrich Weiss; Helmut Laumen; Peter Lichtner; Claudia Ruffert; Jian-Min Chen; Emmanuelle Masson; Sebastian Beer; Constantin Zimmer; Katharina Seltsam; Hana Algül; Florence Bühler; Marco J Bruno; Peter Bugert; Ralph Burkhardt; Giulia Martina Cavestro; Halina Cichoz-Lach; Antoni Farré; Josef Frank; Giovanni Gambaro; Sebastian Gimpfl; Harald Grallert; Heidi Griesmann; Robert Grützmann; Claus Hellerbrand; Péter Hegyi; Marcus Hollenbach; Sevastitia Iordache; Grazyna Jurkowska; Volker Keim; Falk Kiefer; Sebastian Krug; Olfert Landt; Milena Di Leo; Markus M Lerch; Philippe Lévy; Markus Löffler; Matthias Löhr; Maren Ludwig; Milan Macek; Nuria Malats; Ewa Malecka-Panas; Giovanni Malerba; Karl Mann; Julia Mayerle; Sonja Mohr; Rene H M Te Morsche; Marie Motyka; Sebastian Mueller; Thomas Müller; Markus M Nöthen; Sergio Pedrazzoli; Stephen P Pereira; Annette Peters; Roland Pfützer; Francisco X Real; Vinciane Rebours; Monika Ridinger; Marcella Rietschel; Eva Rösmann; Adrian Saftoiu; Alexander Schneider; Hans-Ulrich Schulz; Nicole Soranzo; Michael Soyka; Peter Simon; James Skipworth; Felix Stickel; Konstantin Strauch; Michael Stumvoll; Pier Alberto Testoni; Anke Tönjes; Lena Werner; Jens Werner; Norbert Wodarz; Martin Ziegler; Atsushi Masamune; Joachim Mössner; Claude Férec; Patrick Michl; Joost P H Drenth; Heiko Witt; Markus Scholz; Miklós Sahin-Tóth
Journal:  Gut       Date:  2017-07-28       Impact factor: 23.059

10.  CELA2A mutations predispose to early-onset atherosclerosis and metabolic syndrome and affect plasma insulin and platelet activation.

Authors:  Fatemehsadat Esteghamat; James S Broughton; Emily Smith; Rebecca Cardone; Tarun Tyagi; Mateus Guerra; András Szabó; Nelson Ugwu; Mitra V Mani; Bani Azari; Gerald Kayingo; Sunny Chung; Mohsen Fathzadeh; Ephraim Weiss; Jeffrey Bender; Shrikant Mane; Richard P Lifton; Adebowale Adeniran; Michael H Nathanson; Fred S Gorelick; John Hwa; Miklós Sahin-Tóth; Renata Belfort-DeAguiar; Richard G Kibbey; Arya Mani
Journal:  Nat Genet       Date:  2019-07-29       Impact factor: 41.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.